The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer

Figure 3

(a) The mRNA expression of six IGFBPs in women with serous ovarian cancer. (b) The levels of IGFBPs in the pathological stage II, III, and IV of serous ovarian cancer (GEPIA database). The cut-off of value and fold change was set up at 0.01 and 2, respectively.

(a)

(b)